gemfibrozil has been researched along with Liver Neoplasms in 7 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil is a widely used drug that elevates plasma HDL and lowers triglycerides and LDL." | 1.29 | Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2). ( Chuang, MY; Jin, FY; Kamanna, VS; Kashyap, ML; Morgan, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, D | 1 |
| Ganji, SH | 1 |
| Kamanna, VS | 2 |
| Kashyap, ML | 2 |
| Cattley, RC | 1 |
| Illingworth, R | 1 |
| Jin, FY | 1 |
| Chuang, MY | 1 |
| Morgan, K | 1 |
| Goto, D | 1 |
| Okimoto, T | 1 |
| Ono, M | 1 |
| Shimotsu, H | 1 |
| Abe, K | 1 |
| Tsujita, Y | 1 |
| Kuwano, M | 1 |
| Mohan, WS | 1 |
| Chen, ZQ | 1 |
| Zhang, X | 1 |
| Khalili, K | 1 |
| Honjo, T | 1 |
| Deeley, RG | 1 |
| Tam, SP | 1 |
| Clavey, V | 1 |
| Copin, C | 1 |
| Mariotte, MC | 1 |
| Baugé, E | 1 |
| Chinetti, G | 1 |
| Fruchart, J | 1 |
| Fruchart, JC | 1 |
| Dallongeville, J | 1 |
| Staels, B | 1 |
7 other studies available for gemfibrozil and Liver Neoplasms
| Article | Year |
|---|---|
Effect of gemfibrozil on apolipoprotein B secretion and diacylglycerol acyltransferase activity in human hepatoblastoma (HepG2) cells.
Topics: Acyltransferases; Apolipoproteins B; Diacylglycerol O-Acyltransferase; Gemfibrozil; Hepatoblastoma; | 2002 |
Carcinogenicity of lipid-lowering drugs.
Topics: Acyl-CoA Oxidase; Animals; Gemfibrozil; Humans; Hypolipidemic Agents; Liver; Liver Neoplasms; Microb | 1996 |
Carcinogenicity of lipid-lowering drugs.
Topics: Acyl Coenzyme A; Gemfibrozil; Humans; Hypolipidemic Agents; Liver; Liver Neoplasms; Lovastatin | 1996 |
Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
Topics: Apolipoprotein A-I; Carcinoma, Hepatocellular; Cholesterol; Gemfibrozil; Gene Expression Regulation, | 1996 |
Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
Topics: Carcinoma, Hepatocellular; Dactinomycin; ErbB Receptors; Gemfibrozil; Gene Expression Regulation, Ne | 1997 |
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
Topics: Apolipoprotein A-I; Blotting, Northern; Carcinoma, Hepatocellular; DNA-Binding Proteins; Gemfibrozil | 1998 |
Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Blood; | 1999 |